Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan J Sullivan

Showing results (91-100 of 327) with videos related to

Pageof 33
Sort By:
Cancer|July 6, 2018
High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanomaAlexander T Faje, Donald Lawrence, Keith Flaherty, et al.
Bioactive Materials|January 21, 2025
Fabrication and functional validation of a hybrid biomimetic nanovaccine (HBNV) against <i>Kit</i> <sup></sup> -mutant melanomaKishwor Poudel, Zhenyu Ji, Ching-Ni Njauw, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 21, 2024
Seasonal and geographic variation in cutaneous immune-related adverse events after treatment with immune checkpoint inhibitorsAhmad Rajeh, Katie Roster, Kerry L Reynolds, et al.
Journal for Immunotherapy of Cancer|July 24, 2023
Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug developmentHarriet M Kluger, Hussein Tawbi, David Feltquate, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|November 14, 2017
Immune Checkpoint Inhibitor Cancer Therapy: Spectrum of Imaging FindingsGary X Wang, Vikram Kurra, Justin F Gainor, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 21, 2016
Point of care assessment of melanoma tumor signaling and metastatic burden from μNMR analysis of tumor fine needle aspirates and peripheral bloodMichael S Gee, Arezou A Ghazani, Rizwan Haq, et al.
Journal for Immunotherapy of Cancer|November 9, 2019
Budesonide treatment for microscopic colitis from immune checkpoint inhibitorsMichael S Hughes, Gabriel E Molina, Steven T Chen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 22, 2017
A Retrospective Analysis of the Efficacy of Pembrolizumab in Melanoma Patients With Brain MetastasisIbiayi Dagogo-Jack, Michael Lanfranchi, Justin F Gainor, et al.
JAAD Case Reports|April 23, 2019
The metastatic dissemination of a squamous cell carcinoma arising from an epidermal cyst and subsequent failure to respond to programmed death 1 inhibitionMelissa A Lumish, Mark A Anderson, Patrick S Rush, et al.
Journal of the American Academy of Dermatology|July 7, 2026
Liquid Biopsy in Cutaneous Oncology: Current Practice and Future DirectionsSabah Choudhury, Adewunmi O Adelaja, Haley Ann Neff, et al.
Pageof 33

Showing results (91-100 of 327) with videos related to

Sort By:
Pageof 33
Cancer|July 6, 2018
High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanomaAlexander T Faje, Donald Lawrence, Keith Flaherty, et al.
Bioactive Materials|January 21, 2025
Fabrication and functional validation of a hybrid biomimetic nanovaccine (HBNV) against <i>Kit</i> <sup></sup> -mutant melanomaKishwor Poudel, Zhenyu Ji, Ching-Ni Njauw, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 21, 2024
Seasonal and geographic variation in cutaneous immune-related adverse events after treatment with immune checkpoint inhibitorsAhmad Rajeh, Katie Roster, Kerry L Reynolds, et al.
Journal for Immunotherapy of Cancer|July 24, 2023
Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug developmentHarriet M Kluger, Hussein Tawbi, David Feltquate, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|November 14, 2017
Immune Checkpoint Inhibitor Cancer Therapy: Spectrum of Imaging FindingsGary X Wang, Vikram Kurra, Justin F Gainor, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 21, 2016
Point of care assessment of melanoma tumor signaling and metastatic burden from μNMR analysis of tumor fine needle aspirates and peripheral bloodMichael S Gee, Arezou A Ghazani, Rizwan Haq, et al.
Journal for Immunotherapy of Cancer|November 9, 2019
Budesonide treatment for microscopic colitis from immune checkpoint inhibitorsMichael S Hughes, Gabriel E Molina, Steven T Chen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 22, 2017
A Retrospective Analysis of the Efficacy of Pembrolizumab in Melanoma Patients With Brain MetastasisIbiayi Dagogo-Jack, Michael Lanfranchi, Justin F Gainor, et al.
JAAD Case Reports|April 23, 2019
The metastatic dissemination of a squamous cell carcinoma arising from an epidermal cyst and subsequent failure to respond to programmed death 1 inhibitionMelissa A Lumish, Mark A Anderson, Patrick S Rush, et al.
Journal of the American Academy of Dermatology|July 7, 2026
Liquid Biopsy in Cutaneous Oncology: Current Practice and Future DirectionsSabah Choudhury, Adewunmi O Adelaja, Haley Ann Neff, et al.
Pageof 33